Able Biolabs
PrivateLast Round
Accelerator
Apr 1, 2024
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Able Biolabs is a drug discovery company that provides preclinical and clinical R&D services for clients in the biotech and consumer goods industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Able Biolabs Comparables
Compare Able Biolabs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioModels, LLC | 80% | |
| Reaction Biology Corporation | 72% | |
| Charles River Laboratories | 67% |
Able Biolabs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Apr 1, 2024 |
Able Biolabs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biostack Ventures | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 55% MoM, reaching 1K.
- May 21, 2026
Monthly visitors grew 688% MoM, reaching 5K.
Able Biolabs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Able Biolabs's valuation, stock price, and market status.
Is Able Biolabs a public or private company?
Able Biolabs is a private company.
What is the current stock price of Able Biolabs?
Able Biolabs is a private company with no public stock price. No recent secondary market data is available.
How much is Able Biolabs worth (valuation)?
Valuation information for Able Biolabs is not publicly available.
Can I buy Able Biolabs stock?
Able Biolabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Able Biolabs's last funding round?
Able Biolabs's most recent funding round was Accelerator on April 1, 2024.
Who are the main investors in Able Biolabs?
Key investors in Able Biolabs include Biostack Ventures.
Will Able Biolabs IPO soon?
No public IPO plans have been announced for Able Biolabs.
How can I track Able Biolabs secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Able Biolabs's secondary market activity and sign up for updates.